Our study demonstrates for the first time effects of ERβ inactivation in breast tumorigenesis and provides a valuable mouse model for delineating the tumor-repressive actions of ERβ in the breast and testing chemoprevention strategies. This evidence concerns the gene ESR2 and neoplasm.